scholarly article | Q13442814 |
P50 | author | Chris J L M Meijer | Q90379336 |
Peter J F Snijders | Q90768556 | ||
P2093 | author name string | Meyer T | |
Dillner J | |||
Wadell G | |||
Strand A | |||
Johansson B | |||
von Knebel Doeberitz M | |||
Pfister H | |||
Stockfleth E | |||
Walboomers JM | |||
Forslund O | |||
Jacobs MV | |||
Nindl I | |||
Voorhorst FJ | |||
P2860 | cites work | Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. | Q30452566 |
Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction | Q36081505 | ||
Intermethod variation in detection of human papillomavirus DNA in cervical smears | Q36525380 | ||
A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings | Q36543787 | ||
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. | Q36544266 | ||
Comparison of dot filter hybridization, Southern transfer hybridization, and polymerase chain reaction amplification for diagnosis of anal human papillomavirus infection. | Q37084174 | ||
An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy | Q38467122 | ||
Detection and typing of human papillomaviruses present in fixed and stained archival cervical smears by a consensus polymerase chain reaction and direct sequence analysis allow the identification of a broad spectrum of human papillomavirus types | Q38486887 | ||
The Papanicolaou test for cervical cancer detection. A triumph and a tragedy | Q38597626 | ||
The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes | Q39101956 | ||
Human papillomavirus testing in primary cervical screening. | Q52338437 | ||
Risk Factors for Cervical Cancer in Thailand: a Case-Control Study | Q58296906 | ||
A normal cervical smear and yet cervical cancer | Q67961540 | ||
Recent trends in cervix uteri cancer | Q69777166 | ||
Interlaboratory agreement in a polymerase chain reaction-based human papillomavirus DNA assay | Q71469889 | ||
A non-radioactive PCR enzyme-immunoassay enables a rapid identification of HPV 16 and 18 in cervical scrapes after GP5+/6+ PCR | Q71562461 | ||
Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance | Q72636618 | ||
The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR | Q73108013 | ||
Interlaboratory agreement of different human papillomavirus DNA detection and typing assays in cervical scrapes | Q77392078 | ||
P4510 | describes a project that uses | polymerase chain reaction | Q176996 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 498-503 | |
P577 | publication date | 1999-07-01 | |
P1433 | published in | Journal of Clinical Pathology | Q6294965 |
P1476 | title | Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison | |
P478 | volume | 52 |
Q54573717 | CHAPTER 7 Methods for detection of HPV infection and its clinical utility. |
Q77836045 | Cervical cancer |
Q33893044 | Cervical cytology after 2000: where to go? |
Q36584410 | Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases |
Q35587773 | Chromosome in situ hybridisation, Ki-67, and telomerase immunocytochemistry in liquid based cervical cytology. |
Q35073445 | Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program |
Q36857709 | Detection and typing of human papilloma virus by multiplex PCR with type-specific primers. |
Q82735911 | ELISA test to detect CDKN2A (p16(INK4a)) expression in exfoliative cells: a new screening tool for cervical cancer |
Q53519290 | Emerging biomarkers in the detection, diagnosis and management of cervical dysplasia and carcinoma. |
Q33488325 | Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model |
Q34492018 | Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia |
Q37461977 | Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older |
Q34466134 | HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis |
Q36645480 | HPV Population Profiling in Healthy Men by Next-Generation Deep Sequencing Coupled with HPV-QUEST. |
Q34390791 | High-resolution melting molecular signatures for rapid identification of human papillomavirus genotypes |
Q81404025 | Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial |
Q44751201 | Human papillomavirus detection and typing using a nested-PCR-RFLP assay |
Q40023480 | Human papillomavirus genotype detection in recurrent respiratory papillomatosis (RRP) in Colombia |
Q34305225 | Immunity to oncogenic human papillomaviruses |
Q81102317 | Immunocytochemical staining of p16(ink4a) protein as an adjunct test in equivocal liquid-based cytology |
Q80796966 | Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection |
Q33290324 | Inter-laboratory validation of PCR-based HPV detection in pathology specimens |
Q34773451 | International proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus DNA: evaluation of accuracy and intralaboratory and interlaboratory agreement |
Q33181477 | Intra-laboratory reproducibility of human papillomavirus identification in cervical specimens by a polymerase chain reaction-based assay |
Q37503427 | Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial. |
Q39189708 | Long-term HPV type-specific risks for ASCUS and LSIL: a 14-year follow-up of a randomized primary HPV screening trial |
Q42204957 | Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial. |
Q33973389 | Novel method for detection, typing, and quantification of human papillomaviruses in clinical samples |
Q47345483 | Oncogenic viruses in Skull Base Chordomas |
Q37291430 | Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries |
Q36121308 | Prevalence of human papillomavirus in university young women |
Q34074998 | Recent advances in diagnosis and therapy of human papillomaviruses |
Q92256596 | The potential of RNA as a target for national screening of pre-cancer |
Q34089060 | Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection |
Q54763506 | Type-specific detection of human papillomaviruses in a routine laboratory setting--improved sensitivity and specificity of PCR and sequence analysis compared to direct hybridisation. |
Q47732272 | Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials. |
Q35586592 | p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. |
Search more.